Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Publication year range
1.
Brain ; 2024 Jun 28.
Article in English | MEDLINE | ID: mdl-38938188

ABSTRACT

Charcot-Marie-Tooth (CMT) disease is a neuromuscular disorder affecting the peripheral nervous system. The diagnostic yield in demyelinating CMT (CMT1) is typically ∼80-95%, of which at least 60% is due to the PMP22 gene duplication. The remainder of CMT1 is more genetically heterogeneous. We used whole exome and whole genome sequencing data included in the GENESIS database to investigate novel causal genes and mutations in a cohort of ∼2,670 individuals with CMT neuropathy. A recurrent heterozygous missense variant p.Thr1424Met in the recently described CMT gene ITPR3, encoding IP3R3 (inositol 1,4,5-trisphosphate receptor 3) was identified. This previously reported p.Thr1424Met change was present in 33 affected individuals from nine unrelated families from multiple populations, representing an unusual recurrence rate at a mutational hotspot, strengthening the gene-disease relationship (GnomADv4 allele frequency 1.76e-6). Sanger sequencing confirmed the co-segregation of the CMT phenotype with the presence of the mutation in autosomal dominant and de novo inheritance patterns, including a four-generation family with multiple affected second-degree cousins. Probands from all families presented with slow nerve conduction velocities, matching the diagnostic category of CMT1. Remarkably, we observed a uniquely variable clinical phenotype for age at onset and phenotype severity in p.Thr1424Met carrying patients, even within families. Finally, we present data supportive of a dominant-negative effect of the p.Thr1424Met mutation with associated changes in protein expression in patient-derived cells.

2.
J Mol Cell Cardiol ; 193: 78-87, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38851626

ABSTRACT

Mutations in ubiquitously expressed presenilin genes (PSENs) lead to early-onset familial Alzheimer's disease (FAD), but patients carrying the mutation also suffer from heart diseases. To elucidate the cardiac myocyte specific effects of PSEN ΔE9, we studied cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) from patients carrying AD-causing PSEN1 exon 9 deletion (PSEN1 ΔE9). When compared with their isogenic controls, PSEN1 ΔE9 cardiomyocytes showed increased sarcoplasmic reticulum (SR) Ca2+ leak that was resistant to blockage of ryanodine receptors (RyRs) by tetracaine or inositol-3-reseceptors (IP3Rs) by 2-ABP. The SR Ca2+ leak did not affect electrophysiological properties of the hiPSC-CMs, but according to experiments and in silico simulations the leak induces a diastolic buildup of [Ca2+] near the perinuclear SR and reduces the releasable Ca2+ during systole. This demonstrates that PSEN1 ΔE9 induced SR Ca2+ leak has specific effects in iPSC-CMs, reflecting their unique structural and calcium signaling features. The results shed light on the physiological and pathological mechanisms of PSEN1 in cardiac myocytes and explain the intricacies of comorbidity associated with AD-causing mutations in PSEN1.


Subject(s)
Calcium Signaling , Calcium , Induced Pluripotent Stem Cells , Mutation , Myocytes, Cardiac , Presenilin-1 , Ryanodine Receptor Calcium Release Channel , Sarcoplasmic Reticulum , Humans , Induced Pluripotent Stem Cells/metabolism , Myocytes, Cardiac/metabolism , Presenilin-1/genetics , Presenilin-1/metabolism , Sarcoplasmic Reticulum/metabolism , Calcium/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , Ryanodine Receptor Calcium Release Channel/genetics
3.
Cell Calcium ; 110: 102697, 2023 03.
Article in English | MEDLINE | ID: mdl-36736164

ABSTRACT

Ca2+ is a major ligand of the inositol 1,4,5-trisphosphate receptor (IP3R) Ca2+-release channel. Fan et al. [1] recently solved additional cryo-electron microscopy (cryo-EM) structures of the IP3R in different ligand-binding states, revealing new Ca2+ binding sites.


Subject(s)
Calcium , Inositol 1,4,5-Trisphosphate , Inositol 1,4,5-Trisphosphate Receptors/metabolism , Cryoelectron Microscopy , Ligands , Inositol 1,4,5-Trisphosphate/metabolism , Binding Sites , Calcium/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL